Related Experiment Video
Updated: Feb 5, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Improving Information Exchange with Clinical Trial Participants: A Proposal for Industry
Julie Dietrich1, Jeannine Alivojvodic2, Irene Seliverstov3
11 Development Design Center, Global Development, Amgen Inc, Thousand Oaks, CA, USA.
Background:
Researchers are increasingly motivated to move toward patient-centric drug development. TransCelerate has identified improved "information exchange" as an important component of creating a more satisfying clinical trial experience for patients and their health care professionals (HCPs).
Methods:
Patients, sponsors, sites, and HCPs were engaged through surveys, interviews, and/or advisory boards to capture the current status of information exchange and identify possible future practices between the major stakeholders within the clinical research ecosystem.
Results:
Data suggest that patients have numerous desires and preferences for information exchange during their clinical trial journey that are not commonly met. Various opportunities exist to improve the clinical trial participants' experiences by improving information exchange practices across various stages of the participant's journey.
Conclusions:
A shift in industry focus toward more comprehensive information exchange with trial participants has the potential to positively impact many patients.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Statistical Software for Data Analysis and Clinical Trials
Social Exchange Theory
Gas Exchange and Transport
Trial and Error and Algorithm

